Bifidobacterium catabolism of human milk oligosaccharides overrides endogenous competitive exclusion driving colonization and protection

Understanding how exogenous microbes stably colonize the animal gut is essential to reveal mechanisms of action and tailor effective probiotic treatments. Bifidobacterium species are naturally enriched in the gastrointestinal tract of breast-fed infants. Human milk oligosaccharides (HMOs) are associ...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Britta E. Heiss, Amy M. Ehrlich, Maria X. Maldonado-Gomez, Diana H. Taft, Jules A. Larke, Michael L. Goodson, Carolyn M. Slupsky, Daniel J. Tancredi, Helen E. Raybould, David A. Mills
Formato: article
Lenguaje:EN
Publicado: Taylor & Francis Group 2021
Materias:
Acceso en línea:https://doaj.org/article/d99be7dd45d74118a4b98cf46d46f002
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:d99be7dd45d74118a4b98cf46d46f002
record_format dspace
spelling oai:doaj.org-article:d99be7dd45d74118a4b98cf46d46f0022021-11-04T15:00:42ZBifidobacterium catabolism of human milk oligosaccharides overrides endogenous competitive exclusion driving colonization and protection1949-09761949-098410.1080/19490976.2021.1986666https://doaj.org/article/d99be7dd45d74118a4b98cf46d46f0022021-01-01T00:00:00Zhttp://dx.doi.org/10.1080/19490976.2021.1986666https://doaj.org/toc/1949-0976https://doaj.org/toc/1949-0984Understanding how exogenous microbes stably colonize the animal gut is essential to reveal mechanisms of action and tailor effective probiotic treatments. Bifidobacterium species are naturally enriched in the gastrointestinal tract of breast-fed infants. Human milk oligosaccharides (HMOs) are associated with this enrichment. However, direct mechanistic proof of the importance of HMOs in this colonization is lacking given milk contains additional factors that impact the gut microbiota. This study examined mice supplemented with the HMO 2ʹfucosyllactose (2ʹFL) together with a 2ʹFL-consuming strain, Bifidobacterium pseudocatenulatum MP80. 2ʹFL supplementation creates a niche for high levels of B.p. MP80 persistence, similar to Bifidobacterium levels seen in breast-fed infants. This synergism impacted gut microbiota composition, activated anti-inflammatory pathways and protected against chemically-induced colitis. These results demonstrate that bacterial-milk glycan interactions alone drive enrichment of beneficial Bifidobacterium and provide a model for tunable colonization thus facilitating insight into mechanisms of health promotion by bifidobacteriain neonates.Britta E. HeissAmy M. EhrlichMaria X. Maldonado-GomezDiana H. TaftJules A. LarkeMichael L. GoodsonCarolyn M. SlupskyDaniel J. TancrediHelen E. RaybouldDavid A. MillsTaylor & Francis Grouparticlegut microbiotahuman milk oligosaccharidesbifidobacteriumcolonizationprobioticsDiseases of the digestive system. GastroenterologyRC799-869ENGut Microbes, Vol 13, Iss 1 (2021)
institution DOAJ
collection DOAJ
language EN
topic gut microbiota
human milk oligosaccharides
bifidobacterium
colonization
probiotics
Diseases of the digestive system. Gastroenterology
RC799-869
spellingShingle gut microbiota
human milk oligosaccharides
bifidobacterium
colonization
probiotics
Diseases of the digestive system. Gastroenterology
RC799-869
Britta E. Heiss
Amy M. Ehrlich
Maria X. Maldonado-Gomez
Diana H. Taft
Jules A. Larke
Michael L. Goodson
Carolyn M. Slupsky
Daniel J. Tancredi
Helen E. Raybould
David A. Mills
Bifidobacterium catabolism of human milk oligosaccharides overrides endogenous competitive exclusion driving colonization and protection
description Understanding how exogenous microbes stably colonize the animal gut is essential to reveal mechanisms of action and tailor effective probiotic treatments. Bifidobacterium species are naturally enriched in the gastrointestinal tract of breast-fed infants. Human milk oligosaccharides (HMOs) are associated with this enrichment. However, direct mechanistic proof of the importance of HMOs in this colonization is lacking given milk contains additional factors that impact the gut microbiota. This study examined mice supplemented with the HMO 2ʹfucosyllactose (2ʹFL) together with a 2ʹFL-consuming strain, Bifidobacterium pseudocatenulatum MP80. 2ʹFL supplementation creates a niche for high levels of B.p. MP80 persistence, similar to Bifidobacterium levels seen in breast-fed infants. This synergism impacted gut microbiota composition, activated anti-inflammatory pathways and protected against chemically-induced colitis. These results demonstrate that bacterial-milk glycan interactions alone drive enrichment of beneficial Bifidobacterium and provide a model for tunable colonization thus facilitating insight into mechanisms of health promotion by bifidobacteriain neonates.
format article
author Britta E. Heiss
Amy M. Ehrlich
Maria X. Maldonado-Gomez
Diana H. Taft
Jules A. Larke
Michael L. Goodson
Carolyn M. Slupsky
Daniel J. Tancredi
Helen E. Raybould
David A. Mills
author_facet Britta E. Heiss
Amy M. Ehrlich
Maria X. Maldonado-Gomez
Diana H. Taft
Jules A. Larke
Michael L. Goodson
Carolyn M. Slupsky
Daniel J. Tancredi
Helen E. Raybould
David A. Mills
author_sort Britta E. Heiss
title Bifidobacterium catabolism of human milk oligosaccharides overrides endogenous competitive exclusion driving colonization and protection
title_short Bifidobacterium catabolism of human milk oligosaccharides overrides endogenous competitive exclusion driving colonization and protection
title_full Bifidobacterium catabolism of human milk oligosaccharides overrides endogenous competitive exclusion driving colonization and protection
title_fullStr Bifidobacterium catabolism of human milk oligosaccharides overrides endogenous competitive exclusion driving colonization and protection
title_full_unstemmed Bifidobacterium catabolism of human milk oligosaccharides overrides endogenous competitive exclusion driving colonization and protection
title_sort bifidobacterium catabolism of human milk oligosaccharides overrides endogenous competitive exclusion driving colonization and protection
publisher Taylor & Francis Group
publishDate 2021
url https://doaj.org/article/d99be7dd45d74118a4b98cf46d46f002
work_keys_str_mv AT brittaeheiss bifidobacteriumcatabolismofhumanmilkoligosaccharidesoverridesendogenouscompetitiveexclusiondrivingcolonizationandprotection
AT amymehrlich bifidobacteriumcatabolismofhumanmilkoligosaccharidesoverridesendogenouscompetitiveexclusiondrivingcolonizationandprotection
AT mariaxmaldonadogomez bifidobacteriumcatabolismofhumanmilkoligosaccharidesoverridesendogenouscompetitiveexclusiondrivingcolonizationandprotection
AT dianahtaft bifidobacteriumcatabolismofhumanmilkoligosaccharidesoverridesendogenouscompetitiveexclusiondrivingcolonizationandprotection
AT julesalarke bifidobacteriumcatabolismofhumanmilkoligosaccharidesoverridesendogenouscompetitiveexclusiondrivingcolonizationandprotection
AT michaellgoodson bifidobacteriumcatabolismofhumanmilkoligosaccharidesoverridesendogenouscompetitiveexclusiondrivingcolonizationandprotection
AT carolynmslupsky bifidobacteriumcatabolismofhumanmilkoligosaccharidesoverridesendogenouscompetitiveexclusiondrivingcolonizationandprotection
AT danieljtancredi bifidobacteriumcatabolismofhumanmilkoligosaccharidesoverridesendogenouscompetitiveexclusiondrivingcolonizationandprotection
AT heleneraybould bifidobacteriumcatabolismofhumanmilkoligosaccharidesoverridesendogenouscompetitiveexclusiondrivingcolonizationandprotection
AT davidamills bifidobacteriumcatabolismofhumanmilkoligosaccharidesoverridesendogenouscompetitiveexclusiondrivingcolonizationandprotection
_version_ 1718444801929510912